Algernon Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023
May 02, 2023 at 04:47 am IST
Algernon Pharmaceuticals Inc. reported earnings results for the second quarter and six months ended February 28, 2023. For the second quarter, the company reported net loss was CAD 1.25 million compared to CAD 1.84 million a year ago. Basic loss per share from continuing operations was CAD 0.13 compared to CAD 0.27 a year ago.
For the six months, net loss was CAD 3.13 million compared to CAD 3.04 million a year ago. Basic loss per share from continuing operations was CAD 0.33 compared to CAD 0.46 a year ago.